UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.304-318

2020

Volltextzugriff (PDF)

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Molecular cancer therapeutics, 2009-07, Vol.8 (7), p.1867-1877

2009

Volltextzugriff (PDF)

Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts

BMC biotechnology, 2011-12, Vol.11 (1), p.124-124, Article 124

2011

Volltextzugriff (PDF)

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies

BMC genomics, 2014-05, Vol.15 (1), p.393-393

2014

Volltextzugriff (PDF)

Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture

Frontiers in oncology, 2023-03, Vol.13, p.1091274-1091274

2023

Volltextzugriff (PDF)

Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (19), p.6845-6848

2004

Volltextzugriff (PDF)

Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells

PloS one, 2018-06, Vol.13 (6), p.e0199361-e0199361

2018

Volltextzugriff (PDF)

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

Cancer chemotherapy and pharmacology, 2005-08, Vol.56 (2), p.115-125

2005

Volltextzugriff (PDF)

Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues

PloS one, 2012-12, Vol.7 (12), p.e50494

2012

Volltextzugriff (PDF)

Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy

Journal of pediatric hematology/oncology, 2009-08, Vol.31 (8), p.561-570

2009

Volltextzugriff (PDF)

ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma

Journal of pediatric hematology/oncology, 2011-07, Vol.33 (5), p.360-368

2011

Volltextzugriff (PDF)

Vasocrine formation of tumor cell-lined vascular spaces: Implications for rational design of antiangiogenic therapies

Cancer research (Chicago, Ill.), 2003-06, Vol.63 (11), p.2812-2819

2003

Volltextzugriff (PDF)

Abstract 1961: Preclinical development of NSC-801845, a new cytidine analog, in comparative cell culture and xenograft studies with the clinical candidates T-dCyd and aza-T-dCyd

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1961-1961

2020

Volltextzugriff (PDF)

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

International journal of cancer, 2010-12, Vol.127 (11), p.2510-2519

2010

Volltextzugriff (PDF)

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Molecular cancer therapeutics, 2021-04, Vol.20 (4), p.625-631

2021

Volltextzugriff (PDF)

Abstract 3015: Applications of immunohistochemistry in characterization of patient derived xenograft models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3015-3015

2021

Volltextzugriff (PDF)

Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays

Clinical cancer research, 2016-07, Vol.22 (14), p.3683-3694

2016

Volltextzugriff (PDF)

Abstract 3010: Single agent response comparisons in a large-scale, preclinical trial of rare cancer PDXs by the National Cancer Institute's patient-derived models repository

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3010-3010

2021

Volltextzugriff (PDF)

Abstract 1056: Xenograft-associated B cell lymphoproliferative disease (XABLD) as a surrogate model to study Epstein-Barr virus (EBV) driven B cell Diseases

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1056-1056

2019

Volltextzugriff (PDF)

Abstract 5056: Quality control efforts in a large-scale, preclinical trial of rare cancer PDXs by the National Cancer Institute's patient-derived models repository (NCI PDMR)

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5056-5056

2020

Volltextzugriff (PDF)

Abstract 3554: Genomic landscape of acquired uniparental disomy in NCI PDMR patient derived xenograft models

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3554-3554

2020

Volltextzugriff (PDF)

In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model

Bioorganic & medicinal chemistry letters, 1999-01, Vol.9 (2), p.133-138

1999

Volltextzugriff (PDF)

Abstract 845: A clinically validated multiplex immunofluorescence assay for the quantitative assessment of changes in EMT phenotypes in FFPE tumor tissues in response to cancer therapeutics

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.845-845

2017

Volltextzugriff (PDF)

Abstract 1038: Xenograft-associated B cell lymphoproliferative disease as a surrogate model to study Epstein-Barr virus (EBV) driven lymphoma of the elderly

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1038-1038

2018

Volltextzugriff (PDF)

Assessment of the genomic stability and molecular landscape of patient-derived xenograft (PDX) models from NCI’s Patient-Derived Models Repository (PDMR)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12023-12023

2018

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)
Dissertationen
(1)

Sprache

Englisch
(44)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Animals
(16)
Life Sciences & Biomedicine
(16)
Mice
(15)
Humans
(14)
Oncology
(13)
Cell Line, Tumor
(9)
Female
(9)
Xenograft Model Antitumor Assays
(8)
Mice, Nude
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Tumors
(6)
Cancer Therapies
(5)
Pharmacology. Drug Treatments
(5)
Transplantation, Heterologous
(5)
Antineoplastic Agents - Pharmacology
(4)
Cancer
(4)
Male
(4)
Antineoplastic Agents
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies

Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture

Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts

Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues

Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy

ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma

Vasocrine formation of tumor cell-lined vascular spaces: Implications for rational design of antiangiogenic therapies

Abstract 1961: Preclinical development of NSC-801845, a new cytidine analog, in comparative cell culture and xenograft studies with the clinical candidates T-dCyd and aza-T-dCyd

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Abstract 3015: Applications of immunohistochemistry in characterization of patient derived xenograft models

Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays

Abstract 3010: Single agent response comparisons in a large-scale, preclinical trial of rare cancer PDXs by the National Cancer Institute's patient-derived models repository

Abstract 1056: Xenograft-associated B cell lymphoproliferative disease (XABLD) as a surrogate model to study Epstein-Barr virus (EBV) driven B cell Diseases

Abstract 5056: Quality control efforts in a large-scale, preclinical trial of rare cancer PDXs by the National Cancer Institute's patient-derived models repository (NCI PDMR)

Abstract 3554: Genomic landscape of acquired uniparental disomy in NCI PDMR patient derived xenograft models

In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model

Abstract 845: A clinically validated multiplex immunofluorescence assay for the quantitative assessment of changes in EMT phenotypes in FFPE tumor tissues in response to cancer therapeutics

Abstract 1038: Xenograft-associated B cell lymphoproliferative disease as a surrogate model to study Epstein-Barr virus (EBV) driven lymphoma of the elderly

Assessment of the genomic stability and molecular landscape of patient-derived xenograft (PDX) models from NCI’s Patient-Derived Models Repository (PDMR)

Suchergebnisse filtern